The strategic partnership between the Centre for Drug Research and Development and the NGDI bridges an important gap between drug discovery and clinical trials. This allows our members to move their initial research with access to target validation, drug screening, medicinal chemistry, drug delivery, and evaluation.
The University of British Columbia’s Collaboration for Outcomes Research and Evaluation (CORE) group addresses the need for clinical and economic research, and education in pharmaceutical outcomes assessment. The CORE team is a multidisciplinary group of researchers with expertise in clinical pharmacy, pharmacoepidemiology, health economics, health services research, program evaluation and health promotion research.
Project Funding Partners
Bill & Melinda Gates Foundation
Canadian Coalition for Global Health Research
Canadian Institutes of Health Research
Consortium for Parasitic Drug Development
Government of Canada, Department of Foreign Affairs, Trade and Development
Grand Challenges Canada
iCo Therapeutics Inc.
National Institutes of Health
National Research Council of Canada
Sandra Rotman Centre
Simon Fraser University
World Health Organziation, Tropical Disease Research
World Health Organization, Essential Medicines Department